Chris Mathes, PhD, MBA is an executive with more than 25 years of experience in the biopharmaceutical industry. Mathes has expertise in pre-clinical CRO leadership, sales and marketing.

His scientific background, related to ion channel research and patch clamp technology, has brought a unique and valuable perspective to each role.

Previously, Mathes held executive leadership positions at AnaBios, Icagen, Charles River (ChanTest) and Sophion Bioscience. He earned a BS in Biology from Stanford University, received his PhD in Neuroscience from UCLA and earned an MBA from Rutgers University. His ion channel focused scientific training included post-doctoral research at Stanford University and the Max-Planck Institute for Biophysical Chemistry in Goettingen, Germany and he has published 17 peer reviewed articles. In 2018, he founded Candidate Biopharma Advisors, a consulting firm.